![]()
MIRA INFORM
REPORT
|
Report Date : |
29.06.2011 |
IDENTIFICATION DETAILS
|
Name : |
STAR LABORATORIES (PVT) LIMITED |
|
|
|
|
Registered Office : |
23-Km, Multan Road (Chung) 53800, Lahore |
|
|
|
|
Country : |
Pakistan |
|
|
|
|
Year of Establishment : |
1960 |
|
|
|
|
Com. Reg. No.: |
0006071 |
|
|
|
|
Legal Form : |
Private Limited Company |
|
|
|
|
Line of Business : |
Manufacturing of Human,Veterinary &
Poultry Medicines |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment
Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2011
|
Country Name |
Previous Rating (31.12.2010) |
Current Rating (31.03.2011) |
|
Pakistan |
b2 |
b2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
|
Registered Address
& Factory |
|
23-Km, Multan Road (Chung) 53800,
Lahore-Pakistan |
|
Tel # |
92 (42) 37511331, 37510690, 37512621,
37512622 |
|
Fax # |
92 (42) 37510163, 37512622 |
|
Website |
|
|
Email |
|
a. |
Nature of
Business |
Manufacturing
of Human,Veterinary & Poultry Medicines |
|
b. |
Year Established |
1960 |
|
c. |
Registration # |
0006071 |
Veterinary Medicines Dept
23-KM, Multan Road Lahore, Lahore, Pakistan.
Human Medicines Dept
125-A, Canal View,
Thoker Niaz Beig, Lahore, Pakistan.
Rashid Jahangir & Co.
(Chartered
Accountants)
Room # 34, 2nd Floor, Sadiq Plaza, The Mall,
Lahore, Pakistan
Subject was established as a Partnership
business in 1960 then afterward its legal status was changed to Private Limited
Company in 1978
|
Authorized Capital |
Rs. 12,500,000.00 |
|
Issued & Paid up Capital |
Rs. 11,750,000.00 |
|
Names |
Designation |
|
Mr. Iqbal Hussain Malik Mrs. Salma Malik Mr. Muhammad Asrar Hussain
Malik Mr. Muhammad Asher Hussain
Malik |
Chief Executive Director Director Director |
|
Names |
No. of Shares |
|
Mr. Iqbal Hussain Malik Mrs. Salma Malik Mr. Sardar Ghulam Ahmad Mr. Malik Ashfaq Hussain Mrs. Parveen Siddiqi Mr. Mian Mohd Fayyaz Mr. Mohd Bashir Mr. Mian Ghulam Rabbani Mr. Mohd Saeed Mr. Ghulam Mohiuddin Bhatti Mr. Mohd Nazir Mr. Nasim Akhter Mr. Shamim Akhter Mr. Mohd Yunus
Mr. Mohd Jameel Mr. Avais Ejaz Mr. Attiq Ejaz Mr. Mohsin Ali Ahmed Mr. Mohd Yusuf Mrs. Nasreen Iqbal Miss Mudassara Iqbal Mr. Muhammad Asrar Hussain Malik Mr. Muhammad Asher Hussain Malik Mr. Mian Mohd Sameer Mrs. Mehar Shaukat Ali Mr. Naveed Akber Qureshi Mr. Rehmat Ullah |
254,501 11,613 29,573 18,900 11,813 5,100 3,000 6,000 8,000 7,000 4,000 9,000 12,500 6,000 l6,000 3,000 3,000 2,000 5,000 99,000 99,000 99,000 99,000 99,000 99,000 90,000 85,000 |
A. Subsidiary
None
B. Associated Companies
(1) Champion Trading
Corporation, Pakistan
Manufacture & Marketing of Medicine for Human and veterinary / Poultry use.
307
(Combined Human & Veterinary Division)
|
SECTION |
RATED CAPACITY ON SINGLE SHIFT BASIS |
UTILIZED CAPACITY |
UN-UTILIZED CAPACITY |
|
INJECTIONS: |
|
|
|
|
Ampoules |
70800000 Nos. |
42480000 Nos. |
28320000 Nos. |
|
Vials |
9600000 Nos. |
5760000 Nos. |
3840000 Nos. |
|
Solutions |
240000 Ltr. |
144000 Ltr. |
96000 Ltr. |
TABLETS:
|
|
|
|
Tablets
|
213600000 Nos. |
128160000 Nos. |
85440000 Nos. |
Boluses
|
7200000 Nos. |
4320000 Nos. |
2880000 Nos. |
OINTMENTS:
|
|
|
|
Ointments
|
1728000 Tubes |
NIL |
1728000 Tubes |
LIQUIDS:
|
|
|
|
Syrup/Drops
|
614400 Ltr. |
368640 Ltr. |
245760 Ltr. |
CAPSULES:
|
|
|
|
Capsules
|
9600000 Nos. |
4500000 Nos. |
5100000 Nos. |
POWDERS:
|
|
|
|
Formulated
|
30000000 Pkt. |
15000000 Pkt. |
15000000 Pkt. |
Repacked
|
2880000 Jars/Bags |
1728000 Jars/Bags |
1152000 Jars/Bags |
|
Year |
In Pak Rupees |
|
2009 |
500,000,000/- (Estimated) |
Mainly to Saudi Arabia, Kuwait, Srilanka, Nigeria, Sudan, U.A.E., Mauritius and Mauritania.
In all major cities of Pakistan and 10 countries of the world.
|
Year |
In US Dollar ($) |
|
2008 |
2,500,000/- (Estimated) |
· Bank Al-Habib Limited.
· Bank Al-Falah Limited.
· MCB Bank Limited, Pakistan.
· Standard Chartered Bank, Pakistan.
· Habib Bank Limited, Pakistan.
· Faysal Bank Limited, Pakistan.
Many new products has been obtained and being added into production. The Human Medicines Section is being re-organized with the view to enhance its productivity and sales. Sales promotion of proprietary drugs is being arranged so as to mobilize the sales promotion department. On veterinary side, endeavors are being stepped up to obtain local manufacturing rights of productions of foreign manufacturers, especially, which are already registered and being sold in Pakistan. In order to increase sales of human medicines, registration of Star Laboratories with major government institutions have been applied and being followed up. For the implementation of above program the induction of new investors on the basis of equity participation or joint venture is being solicited.
·
Lahore Chamber of Commerce & Industry.(
|
Currency |
Unit |
Pakistani Rupee |
|
US Dollar |
1 |
Rs. 86.05 |
|
UK Pound |
1 |
Rs. 137.70 |
|
Euro |
1 |
Rs. 122.60 |
Star Laboratories (Pvt.) Limited was established in 1960 and is engaged in manufacture & export of Live Saving Drugs and Medicines for human and veterinary / poultry use. Company’s market reputation is good. Trade relations are reported as fair. Subject can be considered for normal business dealings at usual trade terms and conditions.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.45.05 |
|
UK Pound |
1 |
Rs.71.92 |
|
Euro |
1 |
Rs.64.37 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.